Lv41
560 积分 2024-01-30 加入
Design, synthesis and structure–activity relationship of indolylindazoles as potent and selective covalent inhibitors of interleukin-2 inducible T-cell kinase (ITK)
7天前
已完结
Isoxazole-pyrimidine derivatives as TACC3 inhibitors: A novel modality to targeted cancer therapy
13天前
已完结
Developing an IKZF2 glue degrader
6个月前
已完结
Discovery of a Novel Series of iso-Indolinone-Based Glutarimides as Highly Efficacious and Selective IKZF2 Molecular Glue Degraders
6个月前
已完结
FoxP3 partners up
6个月前
已完结
Discovery of an Orally Bioavailable STING Inhibitor with In Vivo Anti-Inflammatory Activity in Mice with STING-Mediated Inflammation
7个月前
已完结
Amylin: emergent therapeutic opportunities in overweight, obesity and diabetes mellitus
8个月前
已完结
The cGAS-STING axis: a comprehensive review from immune defense to disease pathogenesis
9个月前
已完结
P3.12E.02 MEK Inhibitor Combined with RTK Inhibitor (Trametinib Plus Anlotinib) In Non-g12c KRAS-Mutant Non-Small Cell Lung Cancer: A New Strategy
9个月前
已关闭
P1.02-02 Co-inhibition of MEK/RTKs Pathways via Trametinib Plus Anlotinib forKRAS-Mutant NSCLC
9个月前
已完结
皖公网安备34019202002308
